Menu
Subscribe - Individual
Subscribe - Biotech Premium (Corporate)
Home
About Us
Subscribe
Subscribe Individual
Subscribe Biotech Premium (Corporate)
Premium Biotech Coverage
Current News
Special Features
Company Index
Index Table
Summit
19th Bioshares Biotech Summit
Summit History
Contact
Contact Us
Email Alerts
Home
>
Premium Biotech Coverage
>
Current News
Current News
Categories
Categories
Actinogen (ACW)
Adalta (1AD)
Amplia Therapeutics (ATX)
Anteris Technologies (AVR)
Aroa Biosurgery (ARX)
Blinklab (BB1)
Blog
Botanix (BOT)
Chimeric Therapeutics (CHM)
Clever Culture Systems (CC5)
Clinuvel Pharmaceuticals (CUV)
Cogstate (CGS)
Dimerix (DXB)
EBR Systems (EBR)
Immuron (IMC)
Imugene (IMU)
Island Pharmaceuticals (ILA)
Neuren Pharmaceuticals (NEU)
Patrys (PAB)
Syntara (SNT) (previously Pharmaxis, PXS)
Uncategorized
August 26th, 2025
Actinogen Medical — Why Xanamem Should Deliver Positive Results in Phase IIb Alzheimer’s Disease Study
Read More
August 25th, 2025
Setback for Syntara from FDA Decision
Read More
August 25th, 2025
Neuren Pharmaceuticals — Can DAYBUE Sales Double?
Read More
August 24th, 2025
Argenica — Major Phase II Trial Readout Approaching
Read More
July 29th, 2025
Botanix Share Price Falls on Lower than Expected Margins
Read More
July 28th, 2025
Clever Culture Systems Secures Another Major Pharma Customer
Read More
July 26th, 2025
Imugene to Lead with Azer-cel Program into Pivotal Study Following Additional Complete and Partial Responses. Capital Raise for up to $37.5 Million Underway
Read More
July 11th, 2025
Syntara Phase II Myelofibrosis Data Continues to Get Better
Read More
July 10th, 2025
Strong Profit Upgrade from Cogstate
Read More
July 4th, 2025
Amplia Surges 480% on Pancreatic Cancer Cures
Read More
Pages
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
